Safety and tolerability of lumateperone 42 mg: An open-label antipsychotic switch study in outpatients with stable schizophrenia

Study (301 patients with stable schizophrenia on antipsychotics switched to lumateperone) found significant decreases in in total cholesterol, body weight and prolactin vs previous antipsychotics, with positive and negative schizophrenia symptoms scores remaining stable.

Source:

Schizophrenia research